BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17951291)

  • 1. Metabolomics identifies perturbations in human disorders of propionate metabolism.
    Wikoff WR; Gangoiti JA; Barshop BA; Siuzdak G
    Clin Chem; 2007 Dec; 53(12):2169-76. PubMed ID: 17951291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.
    Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR
    Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.
    Malvagia S; Haynes CA; Grisotto L; Ombrone D; Funghini S; Moretti E; McGreevy KS; Biggeri A; Guerrini R; Yahyaoui R; Garg U; Seeterlin M; Chace D; De Jesus VR; la Marca G
    Clin Chim Acta; 2015 Oct; 450():342-8. PubMed ID: 26368264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of propionylcarnitine in blood and methylmalonic acid in urine of 162 patients with methylmalonic acidemia].
    Wu SN; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):561-5. PubMed ID: 23663331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".
    Minkler PE; Stoll MS; Ingalls ST; Kerner J; Hoppel CL
    Mol Genet Metab; 2015 Dec; 116(4):231-41. PubMed ID: 26458767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of 2-methylcitric acid in dried blood spots improves newborn screening for propionic and methylmalonic acidemias.
    Al-Dirbashi OY; McIntosh N; Chakraborty P
    J Med Screen; 2017 Jun; 24(2):58-61. PubMed ID: 27216769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics studies in cellular models of methylmalonic acidemia and propionic acidemia reveal dysregulation of serine metabolism.
    Anzmann AF; Pinto S; Busa V; Carlson J; McRitchie S; Sumner S; Pandey A; Vernon HJ
    Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165538. PubMed ID: 31449969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESI-MS/MS measurement of free carnitine and its precursor γ-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders.
    Primassin S; Spiekerkoetter U
    Mol Genet Metab; 2010; 101(2-3):141-5. PubMed ID: 20637671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of 1-13C-propionate in vivo in patients with disorders of propionate metabolism.
    Barshop BA; Yoshida I; Ajami A; Sweetman L; Wolff JA; Sweetman FR; Prodanos C; Smith M; Nyhan WL
    Pediatr Res; 1991 Jul; 30(1):15-22. PubMed ID: 1909779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
    Roy C; Tremblay PY; Bienvenu JF; Ayotte P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Untargeted metabolomic analysis hits the target.
    Bennett MJ
    Clin Chem; 2007 Dec; 53(12):2037-9. PubMed ID: 18267928
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma methylcitric acid and its correlations with other disease biomarkers: The impact in the follow up of patients with propionic and methylmalonic acidemia.
    Maines E; Catesini G; Boenzi S; Mosca A; Candusso M; Dello Strologo L; Martinelli D; Maiorana A; Liguori A; Olivieri G; Taurisano R; Piemonte F; Rizzo C; Spada M; Dionisi-Vici C
    J Inherit Metab Dis; 2020 Nov; 43(6):1173-1185. PubMed ID: 32681732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for drug development in propionic and methylmalonic acidemias.
    Longo N; Sass JO; Jurecka A; Vockley J
    J Inherit Metab Dis; 2022 Mar; 45(2):132-143. PubMed ID: 35038174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency presentations of patients with methylmalonic acidemia, propionic acidemia and branched chain amino acidemia (MSUD).
    Henriquez H; el Din A; Ozand PT; Subramanyam SB; al Gain SI
    Brain Dev; 1994 Nov; 16 Suppl():86-93. PubMed ID: 7726386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of free carnitine, individual short- and medium-chain acylcarnitines, and total carnitine in plasma by high-performance liquid chromatography.
    Minkler PE; Hoppel CL
    Anal Biochem; 1993 Aug; 212(2):510-8. PubMed ID: 8214594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns.
    Chace DH; DiPerna JC; Kalas TA; Johnson RW; Naylor EW
    Clin Chem; 2001 Nov; 47(11):2040-4. PubMed ID: 11673377
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of sports activity on carnitine metabolism. Measurement of free carnitine, gamma-butyrobetaine and acylcarnitines by tandem mass spectrometry.
    Inoue F; Terada N; Nakajima H; Okochi M; Kodo N; Kizaki Z; Kinugasa A; Sawada T
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):83-8. PubMed ID: 10491992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential interferents of methylmalonic acid: A previously unrecognized pitfall in clinical diagnostics and newborn screening.
    Monostori P; Godejohann M; Janda J; Galla Z; Rácz G; Klinke G; Szatmári I; Zsidegh P; Kohlmüller D; Kölker S; Hoffmann GF; Gramer G; Okun JG
    Clin Biochem; 2023 Jan; 111():72-80. PubMed ID: 36202155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency.
    Di Donato S; Rimoldi M; Garavaglia B; Uziel G
    Clin Chim Acta; 1984 May; 139(1):13-21. PubMed ID: 6723070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.